4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-036320
Chief Scientific Officer sold 3,000 shares at an average $93.37 ($280,101)
- Chief Scientific Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2018-06-05 | Option exercise | +3,000 | $9.05 | $27,150 | 60,196 | D |
| Biller Scott Chief Scientific Officer | 2018-06-05 | Sale | −802 | $92.45 | $74,145 | 59,394 | D |
| Biller Scott Chief Scientific Officer | 2018-06-05 | Sale | −1,259 | $93.27 | $117,427 | 58,135 | D |
| Biller Scott Chief Scientific Officer | 2018-06-05 | Sale | −939 | $94.28 | $88,529 | 57,196 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-06-05 | Option exercise · Stock options (right to buy) | +3,000 | 19,154 | D | ||
| Open-market sales · 3,000 sh · avg $93.37 · $280,101 | |||||||
Loading xslF345X03/doc4.xml…